Skip to main content

Organ on Chip in Development

Objetivo

Organ-on-chip technology will revolutionize the healthcare domain by offering new and ground breaking solutions to different industries and especially for regenerative medicine and medication.
ORgan-on-Chip In Development (ORCHID) will create a roadmap for organ-on-chip technology and the framework to build a network of relevant stakeholders. ORCHID will achieve this through 5 objectives: (i) evaluation of the technology (state of the art and unmet needs), (ii) identification of ethical issues, establishing standards and identifying measures for regulatory implementation, (iii) analysis of economic and societal impact, training and education, (iv) developing a roadmap which will guide the required R&D efforts and (v) raising awareness and building the ecosystem for organ-on-chip technology through a digital reference platform .
ORCHID will have a broad impact: it will facilitate drug development, contribute significantly to reducing animal experiments and help in developing personalized medicine. ORCHID will achieve these goals by providing a framework to the main stakeholders, bringing together key players and raising awareness on organ-on-chip technology throughout Europe. The digital platform will gather all information on existing and new initiatives in the field. In this way ORCHID as a whole will secure and reinforce Europe’s leadership on organ-on-chip.
The consortium is composed of the main contributors to the field who are all very experienced and who will strongly collaborate with each other. Leiden University Medical Centrum (LUMC) will lead the consortium, the Institute for human Organ and Disease model (hDMT) will focus on the strategy and the roadmap, Fraunhofer IGB on impact assessment, CEA Leti on eco-system development and the digital platform, IMEC on the ethical aspects, regulation and standardization and the University of Zaragoza will lead dissemination. ORCHID will install an Advisory Board composed of complementary specialists in the field.

Ámbito científico

  • /ciencias médicas y de la salud/medicina básica/farmacología y farmacia/medicamento

Convocatoria de propuestas

H2020-FETOPEN-3-2017
Consulte otros proyectos de esta convocatoria

Régimen de financiación

CSA - Coordination and support action

Coordinador

ACADEMISCH ZIEKENHUIS LEIDEN
Dirección
Albinusdreef 2
2333 ZA Leiden
Países Bajos
Tipo de actividad
Higher or Secondary Education Establishments
Aportación de la UE
€ 50 625

Participantes (6)

STICHTING INSTITUTE FOR HUMAN ORGAN AND DISEASE MODEL TECHNOLOGIES
Países Bajos
Aportación de la UE
€ 0
Dirección
Aanschot 85
5629 GZ Eindhoven
Tipo de actividad
Research Organisations
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
Alemania
Aportación de la UE
€ 86 247,50
Dirección
Hansastrasse 27C
80686 Munchen
Tipo de actividad
Research Organisations
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
Francia
Aportación de la UE
€ 85 240
Dirección
Rue Leblanc 25
75015 Paris 15
Tipo de actividad
Research Organisations
INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM
Bélgica
Aportación de la UE
€ 80 235
Dirección
Kapeldreef 75
3001 Leuven
Tipo de actividad
Research Organisations
UNIVERSIDAD DE ZARAGOZA
España
Aportación de la UE
€ 83 375
Dirección
Calle Pedro Cerbuna 12
50009 Zaragoza
Tipo de actividad
Higher or Secondary Education Establishments
TECHNISCHE UNIVERSITEIT DELFT
Países Bajos
Aportación de la UE
€ 134 750
Dirección
Stevinweg 1
2628 CN Delft
Tipo de actividad
Higher or Secondary Education Establishments